Xiang Wang

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 230 citations

LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

Marco A. S. Baptista, Kalpana Merchant, Ted Barrett et al. · Science Translational Medicine · 2020 · 123 citations

Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes

Xiang Wang, Vitaliy V. Bondar, Oliver B. Davis et al. · eLife · 2023 · 41 citations · Full text

Surgical management of traumatic intracranial pseudoaneurysms: A report of 12 cases

Xiang Wang, Jinxiu Chen, Chao You et al. · Neurology India · 2008 · 37 citations · Full text

LRRK2 kinase inhibitors induce a reversible effect in the lungs of non-human primates with no measurable pulmonary deficits

Marco A. S. Baptista, Kalpana Merchant, Ted Barrett et al. · 2018 · 19 citations · Full text

Asthma, Acute Lung Injury, Inflammatory Lung Disease +24